| PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know | 10/22 13:06 | zacks.com |
| Best Momentum Stocks to Buy for October 15th | 10/15 11:00 | zacks.com |
| PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation | 10/02 08:00 | globenewswire.com |
| PDS Biotechnology: Continuing The Holding Pattern | 09/23 10:39 | seekingalpha.com |
| PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024 | 09/09 08:00 | globenewswire.com |
| PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference | 09/03 08:00 | globenewswire.com |
| PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024 | 08/07 08:00 | globenewswire.com |
| PDS Biotechnology Corporation (PDSB) Clinical Program Update Conference Call (Transcript) | 08/02 09:12 | seekingalpha.com |
| PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer | 08/01 07:45 | globenewswire.com |
| PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time | 07/31 16:01 | globenewswire.com |